We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+26.38%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$140B
AUM Growth
+$23.9B
(+21%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
16.71%
Holding
4,310
New
356
Increased
1,988
Reduced
1,282
Closed
383
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Amazon
AMZN
|
+$922M |
| 3 |
Apple
AAPL
|
+$920M |
| 4 |
Otis Worldwide
OTIS
|
+$525M |
| 5 |
Trip.com Group
TCOM
|
+$523M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.9B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$942M |
| 3 |
Linde
LIN
|
+$582M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$392M |
| 5 |
McKesson
MCK
|
+$322M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.27% |
| 2 | Healthcare | 11.06% |
| 3 | Consumer Discretionary | 9.06% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Amneal Pharmaceuticals
AMRX
$5.95B
| $393K | ﹤0.01% |
82,573
-186,032
| -69% | -$766K |
|
3352
Griffon
GFF
$4.72B
| $393K | ﹤0.01% |
21,216
+748
| +4% | +$12.2K |
|
3353
Harte-Hanks
HHS
$16.3M
| $393K | ﹤0.01% |
129,208
-900
| -0.7% | -$2.13K |
|
3354
BRC Group Holdings
RILY
$305M
| $393K | ﹤0.01% |
+18,018
| New | +$345K |
|
|
SHLX
3355
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $393K | ﹤0.01% |
32,059
-11,881
| -27% | -$153K |
|
|
MYOV
3356
DELISTED
Myovant Sciences Ltd.
MYOV
| $392K | ﹤0.01% |
18,999
-11
| -0.1% | -$150 |
|
|
MOBL
3357
DELISTED
MobileIron, Inc.
MOBL
| $389K | ﹤0.01% |
78,884
+38,289
| +94% | +$176K |
|
3358
iShares MSCI Canada ETF
EWC
$6.27B
| $388K | ﹤0.01% |
14,977
-22,575
| -60% | -$552K |
|
3359
Orion
OEC
$363M
| $384K | ﹤0.01% |
36,261
+12,294
| +51% | +$114K |
|
|
ODT
3360
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $384K | ﹤0.01% |
+9,084
| New | +$294K |
|
|
BSTC
3361
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $384K | ﹤0.01% |
+6,278
| New | +$363K |
|
3362
Adtran
ADTN
$656M
| $381K | ﹤0.01% |
34,909
+8,258
| +31% | +$85.3K |
|
3363
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.51B
| $380K | ﹤0.01% |
10,700
-124,400
| -92% | -$4.01M |
|
3364
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
| $380K | ﹤0.01% |
+5,378
| New | +$369K |
|
|
NFH
3365
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $379K | ﹤0.01% |
+45,800
| New | +$372K |
|
3366
Impinj
PI
$5.02B
| $378K | ﹤0.01% |
13,756
+3,082
| +29% | +$72.2K |
|
|
DDG
3367
DELISTED
Proshares Short Oil & Gas
DDG
| $377K | ﹤0.01% |
12,959
+6,066
| +88% | +$192K |
|
3368
First Trust Value Line Dividend Fund
FVD
$8.35B
| $375K | ﹤0.01% |
12,357
-698
| -5% | -$20.8K |
|
3369
Orthofix Medical
OFIX
$424M
| $375K | ﹤0.01% |
11,703
-2,683
| -19% | -$89K |
|
3370
Pennant Group
PNTG
$1.36B
| $375K | ﹤0.01% |
16,606
+946
| +6% | +$19.8K |
|
3371
Comtech Telecommunications
CMTL
$50.3M
| $374K | ﹤0.01% |
22,191
-6,739
| -23% | -$114K |
|
|
HAYN
3372
DELISTED
Haynes International, Inc.
HAYN
| $374K | ﹤0.01% |
16,019
+1,186
| +8% | +$26.4K |
|
3373
Companhia Siderúrgica Nacional
SID
$1.28B
| $369K | ﹤0.01% |
188,359
+8,251
| +5% | +$13.6K |
|
3374
Zumiez
ZUMZ
$335M
| $368K | ﹤0.01% |
13,434
-6,747
| -33% | -$153K |
|
3375
Brookfield Infrastructure
BIPC
$4.93B
| $367K | ﹤0.01% |
+12,075
| New | +$351K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2020 Portfolio in Review
As of Q2 2020, Credit Suisse held 4,310 positions worth $140B, up 21% from $116B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse's Q2 2020 filing shows 356 new, 1,988 increased, 1,282 reduced and 383 closed positions. Its largest new stake was Otis Worldwide: 10,131,011 shares worth $576M. The largest sale was Allergan plc, an estimated $1.9B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Credit Suisse's largest Q2 2020 buy was Otis Worldwide: 10,131,011 shares worth $576M.
- Credit Suisse added most to Microsoft in Q2 2020, an estimated $1.02B increase.
- Credit Suisse's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $942M.
- Credit Suisse fully exited Allergan plc in Q2 2020, selling an estimated $1.9B.
- Credit Suisse's ten largest holdings make up 17% of its $140B portfolio in Q2 2020.
- Credit Suisse opened 356 new positions and closed 383 in Q2 2020.
- Credit Suisse's portfolio value rose 21% quarter-over-quarter to $140B.
Based on Credit Suisse's 13F filing for Q2 2020, filed 12 Aug 2020.